SCHEMBL6601575

SCHEMBL6601575

CCN(C)CCc1ccccc1OC

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.67
SIGMAR1 Q99720 2/20 0.60
BCHE P06276 3/20 0.55
TAAR1 Q96RJ0 1/20 0.55
CHRM2 P08172 3/20 0.54
HTR2A P28223 2/20 0.52
KCNH2 Q12809 1/20 0.47
ACHE P22303 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46
IDO1 P14902 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937482 0.83 AOC3 (0.73) AOC3SIGMAR1BCHETAAR1CHRM2
SCHEMBL27366013 0.82 HTR2A (0.64) AOC3SIGMAR1BCHECHRM2HTR2A
Hydrochloric Acid SCHEMBL8509376 0.81 AOC3 (0.71) AOC3SIGMAR1BCHETAAR1CHRM2
SCHEMBL4514454 0.81 CHRM2 (0.67) AOC3BCHETAAR1CHRM2ACHE
SCHEMBL13579948 0.81 BCHE (0.69) AOC3SIGMAR1BCHECHRM2CYP1A2
SCHEMBL31618107 0.80 HTR2A (0.51) AOC3SIGMAR1HTR2AIDO1CYP1A2
SCHEMBL27375670 0.80 AOC3 (0.64) AOC3SIGMAR1BCHETAAR1CHRM2
SCHEMBL28858018 0.78 TAAR1 (0.75) AOC3SIGMAR1TAAR1CHRM2KCNH2
SCHEMBL6601574 0.77 AOC3 (0.65) AOC3SIGMAR1BCHETAAR1CHRM2
SCHEMBL158584 0.77 TAAR1 (0.67) AOC3SIGMAR1TAAR1CHRM2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417190-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgen Inc. (US) 2004-05-12 EP disclosed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO disclosed